ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 268 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,921 | -5.6% | 73,898 | +3.9% | 0.00% | – |
| Q1 2024 | $2,035 | +9.8% | 71,136 | +17.4% | 0.00% | – |
| Q4 2023 | $1,854 | +36.3% | 60,568 | +19.7% | 0.00% | – |
| Q3 2023 | $1,360 | -30.3% | 50,588 | -7.6% | 0.00% | – |
| Q2 2023 | $1,952 | +47.7% | 54,726 | +5.2% | 0.00% | – |
| Q1 2023 | $1,322 | -35.8% | 52,020 | +2.5% | 0.00% | – |
| Q4 2022 | $2,059 | -99.9% | 50,760 | -0.2% | 0.00% | – |
| Q3 2022 | $1,682,000 | +3.4% | 50,882 | +10.2% | 0.00% | – |
| Q2 2022 | $1,626,000 | -27.5% | 46,186 | -5.2% | 0.00% | – |
| Q1 2022 | $2,242,000 | -24.3% | 48,741 | +9.1% | 0.00% | – |
| Q4 2021 | $2,961,000 | -0.5% | 44,657 | -6.3% | 0.00% | – |
| Q3 2021 | $2,976,000 | -24.4% | 47,667 | +0.3% | 0.00% | – |
| Q2 2021 | $3,937,000 | +16.4% | 47,539 | -6.8% | 0.00% | – |
| Q1 2021 | $3,382,000 | -20.5% | 50,997 | -8.1% | 0.00% | – |
| Q4 2020 | $4,256,000 | +38.7% | 55,467 | -22.2% | 0.00% | – |
| Q3 2020 | $3,069,000 | +2.1% | 71,276 | +2.4% | 0.00% | – |
| Q2 2020 | $3,007,000 | +73.4% | 69,626 | +15.6% | 0.00% | – |
| Q1 2020 | $1,734,000 | -23.3% | 60,255 | +69.0% | 0.00% | – |
| Q4 2019 | $2,261,000 | +200.7% | 35,652 | +33.5% | 0.00% | – |
| Q3 2019 | $752,000 | -24.0% | 26,698 | -28.4% | 0.00% | – |
| Q2 2019 | $989,000 | +22.6% | 37,304 | -15.2% | 0.00% | – |
| Q1 2019 | $807,000 | +35.9% | 43,994 | -8.1% | 0.00% | – |
| Q4 2018 | $594,000 | -20.8% | 47,863 | +22.4% | 0.00% | – |
| Q3 2018 | $750,000 | +43.4% | 39,109 | +1.7% | 0.00% | – |
| Q2 2018 | $523,000 | +91.6% | 38,468 | +1.5% | 0.00% | – |
| Q1 2018 | $273,000 | +96.4% | 37,900 | 0.0% | 0.00% | – |
| Q4 2017 | $139,000 | +26.4% | 37,900 | +49.2% | 0.00% | – |
| Q3 2017 | $110,000 | +168.3% | 25,400 | 0.0% | 0.00% | – |
| Q2 2017 | $41,000 | -12.8% | 25,400 | -0.7% | 0.00% | – |
| Q1 2017 | $47,000 | +17.5% | 25,567 | 0.0% | 0.00% | – |
| Q4 2016 | $40,000 | -78.7% | 25,567 | 0.0% | 0.00% | – |
| Q3 2016 | $188,000 | +37.2% | 25,567 | -0.5% | 0.00% | – |
| Q2 2016 | $137,000 | – | 25,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |